5 Early Q1 Earnings Winners Beating Expectations - Boston Scientific (NYSE:BSX), GE Vernova (NYSE:GEV)

Believe it or not, earnings season is once again upon us, and some crucial large-cap stocks like Tesla, American Express, and Intel already reported results this week.

However, the earnings party began early for the five companies we'll be discussing today, which handily beat top- and bottom-line projections.

And despite the outsized pop each company's stock received following its earnings report, there's fundamental or technical evidence that the momentum underlying the moves has the strength to carry into the second half of 2026.

Here are the five “earnings heroes” with more room to run.

GE Verona Inc.

General Electric spinoff GE Verona (NYSE:GEV) was the big earnings winner this week, soaring more than 12% following an astounding beat and optimistic guidance. The $300 billion company reported an EPS and revenue beat, with sales growing more than 17% year-over-year (YOY).

The standout number remains the backlog; management announced a 2027 backlog of more than $200 billion, a figure it didn't expect to reach until 2028. The Electrification backlog stands at $42 billion, and the company booked more than $2.4 billion in data center equipment orders in Q1 2026. The stock received seven price target boosts following the earnings release, including a new Street-high target of $1,400 from Baird.

GEV shares have been riding a wave of bullish momentum since early last year, and the stock is up more than 240% in the last 12 months. But despite these eye-popping gains, the fundamental and technical momentum remains strong. In addition to the backlog and earnings beats, GEV has strong price support at the 50-day moving average and a Relative Strength Index (RSI) that refuses to turn bearish. The Moving Average Convergence Divergence (MACD) indicator also shows accelerating bullish momentum, so it’s likely GEV shares have yet to reach ‘take profits' territory.

Intuitive Surgical Inc.

Intuitive Surgical (NASDAQ:ISRG) is the designer and manufacturer of the Da Vinci system, which assists surgeons during operations. Despite having just a single product, Intuitive Surgical continues to beat earnings expectations, but the stock has struggled to find its footing of late. Since hitting a new all-time high in January 2025, the stock has been range-bound and has started 2026 with a 15% year-to-date (YTD) loss.

But ISRG's fortunes could be changing: the company had a fabulous Q1 2026, notching a 30% upside surprise on EPS and 23% YOY revenue growth. The company also expects 15% growth in procedures done using the Da Vinci machine after placing 431 new units into service in 2025.

Despite its near-monopoly, Intuitive Surgical is in the midst of a massive drawdown, losing more than 15% YTD. The post-earnings pop finally took shares back above the 50-day moving average, and there's hope this rally sticks, considering the bullish activity on the RSI and MACD. Intuitive Surgical has the earnings tailwinds; now it needs technical momentum to finally break out of this rut, and it looks like it’s about to get it.

Masco Corp.

Masco Corp. (NYSE:MAS) is a surprising earnings winner, given the number of tariff headwinds it faced last year. The $14.9 billion company is a designer and distributor of home improvement products for both commercial and residential clients. Many of the company's offerings, such as faucets, showerheads, cabinets, and paints, were under constant threat of tariffs from the Trump administration last year, and the stock had a volatile 12-month performance.

But Masco shook off these concerns, and revenue is now recovering. In its Q1 2026 release, the company reported a top- and bottom-line beat for the first time since Q4 2023, including an 18% upside surprise on EPS. Management was cautious on guidance, citing elevated commodity costs as a potential offset to tariff relief. But the $19.2 billion in Q1 2026 revenue marked the first quarter of YOY revenue growth since Q2 2022, and the cautious guidance gives lots of room for more upside surprises.

MAS shares bottomed out in March before the earnings release, but an uptrending MACD spotted the change in investor behavior right near the low. Both the MACD and RSI had been trending upward since the bottom formed, and the breakout has now taken the share price back above the 50-day and 200-day moving averages. One area of concern: the RSI is approaching extreme overbought territory, which could signal that a pullback is on the horizon.

Boston Scientific Inc.

Medical device manufacturer Boston Scientific (NYSE:BSX) is another earnings winner hoping to break out of a long slump. The stock is already down more than 30% YTD, taking the price back to levels not seen since January 2024. Erasing more than two years of gains is a very significant drawdown, and picking the bottom on these stocks is a difficult endeavor.

However, BSX is showing signs of a reversal of this downswing. The company had a modest Q1 2026 EPS and revenue beat, and sales grew by more than 11% in the period. And despite lowering its organic growth guidance projections for 2026, the stock rallied through its long-term downtrend line to put up its best performance in months.

The RSI and MACD also hint at bullish energy. The MACD formed a crucial bullish cross more than two months ago in February, and the RSI appears to be finally taking a meaningful bounce above the Oversold threshold. If the drawdown is halted here, the stock has lost nearly 40% of its value since September 2025, which gives brave investors plenty of upside.

Rogers Communications Inc.

Rogers Communications (NYSE:RCI) might be the most boring company on our list today: a Canadian telecommunications giant with a $20 billion market cap and nearly 4% dividend yield. Companies like Rogers are usually for the more risk-averse part of your portfolio, but it did just announce a capital-spending cut that the market liked during its Q1 2026 earnings report. Rogers posted a top- and bottom-line beat, and announced a 30% target for capital spending reductions. These reductions will help the company increase free cash flow, and management raised its free cash flow guidance to CAD 4.1 to CAD 4.3 billion.

RCI shares jumped 13.6% following the report, shaking off the downward momentum and retaking the 200-day moving average. The secondary indicators are also turning bullish, and a move back above the 50-day moving average could likely re-ignite the buying pressure.

BSXBoston Scientific Corp

ISRGIntuitive Surgical Inc

$403.950.44%

MASMasco Corp

$72.62-2.91%

RCIRogers Communications Inc

$37.16-2.49%

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.